In the last 20 years, mechanical circulatory supports (MCS) have overturned completely the outcomes and the clinical recovery of patients with isolated acute left ventricle failure (iALVF). This usually occurs more frequently than right-sided heart failure or biventricular dysfunction, and it mainly is caused by acute myocardial infarction. The primary role of MCS is to restore the tissue metabolism to preserve the vital organs’ function but, on the other hand, they also have to relieve the workload stress on the heart. In this way, they allow not only the heart to recover from the acute event, but MCS also can stabilize the patient toward cardiac transplantation. The short-term MCS devices currently used in clinical practice are the intraaortic balloon pump, the Impella (Abiomed, Danvers, MA), and venoarterial extracorporeal membrane oxygenation (VA-ECMO), but the choice of the right and tailored device for each patient, as well as the timing to use it, is actually one of the most debated topics of MCS management.

Loforte A., Comentale G., Botta L., Gliozzi G., Cavalli G.G., Mariani C., et al. (2022). How Would the Authors Treat Their Own Temporary Left Ventricular Failure With Mechanical Circulatory Support?. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 36(5), 1238-1250 [10.1053/j.jvca.2021.10.020].

How Would the Authors Treat Their Own Temporary Left Ventricular Failure With Mechanical Circulatory Support?

Loforte A.;Comentale G.;Botta L.;Gliozzi G.;Cavalli G. G.;Mariani C.;Pilato E.;Martin Suarez S.;Pacini D.
2022

Abstract

In the last 20 years, mechanical circulatory supports (MCS) have overturned completely the outcomes and the clinical recovery of patients with isolated acute left ventricle failure (iALVF). This usually occurs more frequently than right-sided heart failure or biventricular dysfunction, and it mainly is caused by acute myocardial infarction. The primary role of MCS is to restore the tissue metabolism to preserve the vital organs’ function but, on the other hand, they also have to relieve the workload stress on the heart. In this way, they allow not only the heart to recover from the acute event, but MCS also can stabilize the patient toward cardiac transplantation. The short-term MCS devices currently used in clinical practice are the intraaortic balloon pump, the Impella (Abiomed, Danvers, MA), and venoarterial extracorporeal membrane oxygenation (VA-ECMO), but the choice of the right and tailored device for each patient, as well as the timing to use it, is actually one of the most debated topics of MCS management.
2022
Loforte A., Comentale G., Botta L., Gliozzi G., Cavalli G.G., Mariani C., et al. (2022). How Would the Authors Treat Their Own Temporary Left Ventricular Failure With Mechanical Circulatory Support?. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 36(5), 1238-1250 [10.1053/j.jvca.2021.10.020].
Loforte A.; Comentale G.; Botta L.; Gliozzi G.; Cavalli G.G.; Mariani C.; Pilato E.; Martin Suarez S.; Pacini D.
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1053077021009393-main.pdf

accesso riservato

Tipo: Versione (PDF) editoriale
Licenza: Licenza per accesso riservato
Dimensione 1.68 MB
Formato Adobe PDF
1.68 MB Adobe PDF   Visualizza/Apri   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/902725
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact